Mechanisms of Genomic Instabilities Underlying Two Common Fragile-Site-Associated Loci, PARK2 and DMD, in Germ Cell and Cancer Cell Lines
Jun Mitsui(The University of Tokyo), Shoji Tsuji(The University of Tokyo), Shunpei Ishikawa(The University of Tokyo), Alexis Brice(Inserm), Yuji Takahashi(The University of Tokyo), Narihiro Minami(National Center of Neurology and Psychiatry), Ichizo Nishino(National Center of Neurology and Psychiatry), Suzanne Lesage(Centre National de la Recherche Scientifique), Jun Goto(Kumamoto University), Hiroyuki Tomiyama(German Center for Neurodegenerative Diseases), Hiroyuki Aburatani(The University of Tokyo), Hiroyo Yoshino(Juntendo University), Nobutaka Hattori(Juntendo University Hospital)
Cited by 95
Related Papers
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
|Nature Genetics|2000|2k
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
|The Journal of Cell Biology|2010|1.9k
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
|Cancer Cell|2012|1.4k